Steady-State Pharmacokinetics of Amprenavir Coadministered with Ritonavir in Human Immunodeficiency Virus Type 1-Infected Patients

The protease inhibitor (PI) ritonavir is used as a strong inhibitor of cytochrome P450 3A4, which boosts the activities of coadministered PIs, resulting in augmented plasma PI levels, simplification of the dosage regimen, and better efficacy against resistant viruses. The objectives of the present o...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Goujard, Cecile, Vincent, Isabelle, Meynard, Jean-Luc, Choudet, Nathalie, Bollens, Diane, Rousseau, Cyril, Demarles, Didier, Gillotin, Catherine, Bidault, Roselyne, Taburet, Anne-Marie
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2003
Aiheet:
Pharmacology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC148948/
https://ncbi.nlm.nih.gov/pubmed/12499178
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.47.1.118-123.2003
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia